Glaucoma and Alzheimer: Neurodegenerative disorders show an adrenergic dysbalance. by Bettina Hohberger, Harald Prüss, Christian Mardin, Robert Lämmer, Johannes Müller, Gerd Wallukat

“…Moreover, the long chain Aß1-40, Aβ1-42, and Aβ10-37, yet not the short-chain Aß peptides prevented the clenbuterol induced desensitization of the ß2-AR. In addition, we identified functional autoantibodies in the sera of AD patients, activating the ß2-AR, like the ß2-agAAb found in patients with glaucoma. …”
Get full text

Glaucoma and Alzheimer: Neurodegenerative disorders show an adrenergic dysbalance by Bettina Hohberger, Harald Prüss, Christian Mardin, Robert Lämmer, Johannes Müller, Gerd Wallukat

“…Moreover, the long chain Aß1-40, Aβ1–42, and Aβ10–37, yet not the short-chain Aß peptides prevented the clenbuterol induced desensitization of the ß2-AR. In addition, we identified functional autoantibodies in the sera of AD patients, activating the ß2-AR, like the ß2-agAAb found in patients with glaucoma. …”
Get full text